These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6142427)

  • 41. Action of pyrazolopyridines as modulators of [3H]flunitrazepam binding to the gaba/benzodiazepine receptor complex of the cerebellum.
    Supavilai P; Karobath M
    Eur J Pharmacol; 1981 Mar; 70(2):183-93. PubMed ID: 6114867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of non-sedative anxiolytic drugs on responses to GABA and on diazepam-induced enhancement of these responses on mouse neurones in cell culture.
    De Deyn PP; Macdonald RL
    Br J Pharmacol; 1988 Sep; 95(1):109-20. PubMed ID: 2905900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discriminative stimulus effects of positive GABAA modulators and other anxiolytics, sedatives, and anticonvulsants in untreated and diazepam-treated monkeys.
    McMahon LR; France CP
    J Pharmacol Exp Ther; 2003 Jan; 304(1):109-20. PubMed ID: 12490581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of [3H]flunitrazepam binding by mianserin, in vivo.
    Jeevanjee F; Johnson AM; Loudon JM; Nicholass JM
    Neurosci Lett; 1984 May; 46(3):305-9. PubMed ID: 6330626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the kinetics of [3H]diazepam and [3H]flunitrazepam binding to cortical synaptosomal membranes.
    Chiu TH; Rosenberg HC
    J Neurochem; 1982 Dec; 39(6):1716-25. PubMed ID: 6128377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of GABA and benzodiazepine antagonists on [3H]flunitrazepam binding to cerebral cortical membrane.
    Fong J; Okada K; Lew JY; Goldstein M
    Brain Res; 1983 Apr; 266(1):152-4. PubMed ID: 6133589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Behavioral studies with anxiolytic drugs. II. Interactions of zopiclone with ethyl-beta-carboline-3-carboxylate and Ro 15-1788 in squirrel monkeys.
    Barrett JE; Brady LS; Stanley JA; Mansbach RS; Witkin JM
    J Pharmacol Exp Ther; 1986 Feb; 236(2):313-9. PubMed ID: 2868115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence that the anticonflict effect of midazolam in amygdala is mediated by the specific benzodiazepine receptors.
    Petersen EN; Braestrup C; Scheel-Krüger J
    Neurosci Lett; 1985 Feb; 53(3):285-8. PubMed ID: 2984608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Photoaffinity labeling of different benzodiazepine receptors at physiological temperature.
    Eichinger A; Sieghart W
    J Neurochem; 1984 Dec; 43(6):1745-8. PubMed ID: 6092547
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benzodiazepine receptor ligands with opposing pharmacologic actions.
    Petrack B; Czernik AJ; Cassidy JP; Bernard P; Yokoyama N
    Adv Biochem Psychopharmacol; 1983; 38():129-37. PubMed ID: 6142600
    [No Abstract]   [Full Text] [Related]  

  • 51. Autoradiographic demonstration of the selectivity of two 1-N-trifluoroethyl benzodiazepines for the BZD-1 receptors in the rat brain.
    Wamsley JK; Golden JS; Yamamura HI; Barnett A
    Pharmacol Biochem Behav; 1985 Dec; 23(6):973-8. PubMed ID: 2867566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Behavioral pharmacology of zopiclone.
    Ueki S
    Sleep; 1987; 10 Suppl 1():1-6. PubMed ID: 2894069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Benzodiazepine antagonist Ro 15-1788: binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels.
    Möhler H; Burkard WP; Keller HH; Richards JG; Haefely W
    J Neurochem; 1981 Sep; 37(3):714-22. PubMed ID: 6268754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.
    Giusti P; Ducić I; Puia G; Arban R; Walser A; Guidotti A; Costa E
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1018-28. PubMed ID: 8394902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The quinolines PK 8165 and PK 9084 possess benzodiazepine-like activity in vitro but not in vivo.
    Keane PE; Simiand J; Morre M
    Neurosci Lett; 1984 Mar; 45(1):89-93. PubMed ID: 6145125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors.
    Wesołowska A
    Eur J Pharmacol; 2008 Feb; 580(3):355-60. PubMed ID: 18096153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. II. In vitro and in vivo interactions with benzodiazepine binding sites.
    Keane PE; Bachy A; Morre M; Biziere K
    J Pharmacol Exp Ther; 1988 May; 245(2):699-705. PubMed ID: 2896795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression and pharmacology of human GABAA receptors containing gamma 3 subunits.
    Hadingham KL; Wafford KA; Thompson SA; Palmer KJ; Whiting PJ
    Eur J Pharmacol; 1995 Nov; 291(3):301-9. PubMed ID: 8719414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological properties of tracazolate: a new non-benzodiazepine anxiolytic agent.
    Patel JB; Malick JB
    Eur J Pharmacol; 1982 Mar; 78(3):323-33. PubMed ID: 6121711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
    Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
    Neuropharmacology; 2000 Jul; 39(10):1858-64. PubMed ID: 10884566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.